xmlns:xalan=”https://xml.apache.org/xalan”>KILDE:

xmlns:xalan=”https://xml.apache.org/xalan”>Mayo Clinic: “Benign prostatic hyperplasi: Definition” “Benign prostatic hyperplasi: Behandlinger og Medicin,” “Minimalt invasive kirurgi: Definition.”

xmlns:xalan=”https://xml.apache.org/xalan”>Urology Care Foundation: “Hvad Er Symptomerne på BPH?””Benign prostatahyperplasi (BPH): kirurgi,” “BPH: minimalt Invasive operationer,” “hvad er Transurethral Elektroevaporation af prostata (TUVP)?,”

xmlns:xalan=”https://xml.apache.org/xalan”>UCLA Health: “Conditions Treated: BPH.”

xmlns:xalan=”https://xml.apache.org/xalan”>U.S. Food & Drug Administration: “5-alpha reductase inhibitors (5-ARIs): Label Change – Increased Risk of Prostate Cancer.”

xmlns:xalan=”https://xml.apache.org/xalan”>National Institutes of Health, National Center for Complementary and Integrative Health: “Saw Palmetto.”

xmlns:xalan=”https://xml.apache.org/xalan”>FDA website.,

xmlns:xalan=”https://xml.apache.org/xalan”>American Urological Association: “Benign Prostatic Hyperplasia (BPH): A Patient’s Guide,” “Benign Prostatic Hyperplasia (BPH), Clinical Guidelines.”

xmlns:xalan=”https://xml.apache.org/xalan”>Agency for Healthcare Policy Research.

xmlns:xalan=”https://xml.apache.org/xalan”>William Jaffe, MD, professor of urology, Temple University School of Medicine, Philadelphia.,

xmlns:xalan=”https://xml.apache.org/xalan”>National Kidney and Urologic Diseases Information Clearinghouse (NKUDIC): “Prostate Enlargement: Benign Prostatic Hyperplasia.”

xmlns:xalan=”https://xml.apache.org/xalan”>BJU International: “High-grade prostate cancer and finasteride.”

xmlns:xalan=”https://xml.apache.org/xalan”>Winchester Hospital: “Health Library: Saw Palmetto”

xmlns:xalan=”https://xml.apache.org/xalan”>Casabé A, Roehrborn CG, Da Pozzo LF, et al., “Effektivitet og sikkerhed ved samtidig administration af tadalafil en gang dagligt med finasterid i 6 måneder hos mænd med lavere urinvejssymptomer og prostataforstørrelse sekundært med godartet prostatahyperplasi.”J Urol.2014;191:727-733

xmlns:xalan=”https://xml.apache.org/xalan”>Porst H, Kim ED, Casabé AR, et al. “Effekt og sikkerhed af tadalafil en gang dagligt til behandling af mænd med lavere urinvejssymptomer, der tyder på godartet prostatahyperplasi: resultater af en international randomiseret, dobbeltblind, placebokontrolleret undersøgelse.”Eur Urol.2011;60:1105-1113.